Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 1;33(6):580-590.
doi: 10.1097/MOP.0000000000001069.

Worldwide epidemiology of neuro-coronavirus disease in children: lessons for the next pandemic

Affiliations
Review

Worldwide epidemiology of neuro-coronavirus disease in children: lessons for the next pandemic

Alicia M Alcamo et al. Curr Opin Pediatr. .

Abstract

Purpose of review: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has overwhelmed the global community, negatively impacting patient health and research efforts; associated neurological manifestations are a significant cause of morbidity. This review outlines the worldwide epidemiology of neurologic manifestations of different SARS-CoV-2 clinical pediatric phenotypes, including acute coronavirus disease 2019 (COVID-19), multisystem inflammatory syndrome in children (MIS-C) and postacute sequelae of COVID-19 (PASC). We discuss strategies to develop adaptive global research platforms for future investigation into emerging pediatric neurologic conditions.

Recent findings: Multicenter, multinational studies show that neurological manifestations of acute COVID-19, such as smell/taste disorders, headache, and stroke, are common in hospitalized adults (82%) and children (22%), associated with increased mortality in adults. Neurological manifestations of MIS-C are reported in up to 20% of children, including headache, irritability, and encephalopathy. Data on PASC are emerging and include fatigue, cognitive changes, and headache. Reports of neurological manifestations in each phenotype are limited by lack of pediatric-informed case definitions, common data elements, and resources.

Summary: Coordinated, well resourced, multinational investigation into SARS-CoV-2-related neurological manifestations in children is critical to rapid identification of global and region-specific risk factors, and developing treatment and mitigation strategies for the current pandemic and future health neurologic emergencies.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Timeline of SARS-CoV-2 Pandemic. CDC, Centers for Disease Control and Prevention; EUA, emergency use authorization; FDA, Food and Drug Administration; MIS-C, multisystem inflammatory syndrome in children. Adapted from ‘Timeline (8 Segments, Vertical)’, by BioRender.com (2020).
Box 1
Box 1
no caption available
FIGURE 2
FIGURE 2
Preparing for the Next Pandemic. Adapted from ‘Global Presence (World Map)’, by BioRender.com (2020).

References

    1. Zhu N, Zhang D, Wang W, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727–733. - PMC - PubMed
    1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91:157–160. - PMC - PubMed
    1. Robinson CP, Busl KM. Neurologic manifestations of severe respiratory viral contagions. Crit Care Explor 2020; 2:e0107. - PMC - PubMed
    1. Carod-Artal FJ. Neurological complications of Zika virus infection. Expert Rev Anti Infect Ther 2018; 16:399–410. - PubMed
    1. WHO. WHO Coronavirus (COVID-19) Dashboard [Internet]. Geneva: World Health Organization; 2020 [cited July 12, 2021]. Available from: https://covid19.who.int.
    2. This website is continually updated to demostrate the global epidemiological impact of SARS-CoV-2.

Publication types

Supplementary concepts